33470844 34680807 34631110 34542637 35862943 34058337 34043457 34060899 35097154 35007135 35053103 35529051 31748318 34864936 35415194 36328637 33375493 35745475 - Search Results

Year	Number of Results
2020	2
2021	7
2022	9
2023	0

1

Effect of antimicrobials on Stenotrophomonas maltophilia biofilm.

Santos Carvalhais BE, Souza E Silva C, Dos Santos KV. Santos Carvalhais BE, et al. Future Microbiol. 2021 Jan;16(2):83-93. doi: 10.2217/fmb-2020-0115. Epub 2021 Jan 20. Future Microbiol. 2021. PMID: 33470844

2

Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies.

Gibb J, Wong DW. Gibb J, et al. Antibiotics (Basel). 2021 Oct 9;10(10):1226. doi: 10.3390/antibiotics10101226. Antibiotics (Basel). 2021. PMID: 34680807 Free PMC article. Review.

3

Prevalence of resistance genes and antibiotic resistance profile among Stenotrophomonas maltophilia isolates from hospitalized patients in Iran.

Baseri Z, Dehghan A, Yaghoubi S, Razavi S. Baseri Z, et al. New Microbes New Infect. 2021 Sep 9;44:100943. doi: 10.1016/j.nmni.2021.100943. eCollection 2021 Nov. New Microbes New Infect. 2021. PMID: 34631110 Free PMC article.

4

Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision.

Fratoni AJ, Nicolau DP, Kuti JL. Fratoni AJ, et al. J Antimicrob Chemother. 2021 Dec 24;77(1):164-168. doi: 10.1093/jac/dkab344. J Antimicrob Chemother. 2021. PMID: 34542637

5

Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values.

Vialichka A, Biagi M, Meyer K, Wu T, Shajee A, Tan X, Wenzler E. Vialichka A, et al. Microbiol Spectr. 2022 Aug 31;10(4):e0270521. doi: 10.1128/spectrum.02705-21. Epub 2022 Jul 11. Microbiol Spectr. 2022. PMID: 35862943 Free PMC article.

6

Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.

Junco SJ, Bowman MC, Turner RB. Junco SJ, et al. Int J Antimicrob Agents. 2021 Aug;58(2):106367. doi: 10.1016/j.ijantimicag.2021.106367. Epub 2021 May 28. Int J Antimicrob Agents. 2021. PMID: 34058337

7

Advances in the Microbiology of Stenotrophomonas maltophilia.

Brooke JS. Brooke JS. Clin Microbiol Rev. 2021 Jun 16;34(3):e0003019. doi: 10.1128/CMR.00030-19. Epub 2021 May 26. Clin Microbiol Rev. 2021. PMID: 34043457 Free PMC article.

8

StenoSCORE: Predicting Stenotrophomonas maltophilia Bloodstream Infections in the Hematologic Malignancy Population.

Karaba SM, Goodman KE, Amoah J, Cosgrove SE, Tamma PD. Karaba SM, et al. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0079321. doi: 10.1128/AAC.00793-21. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 34060899 Free PMC article.

9

Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.

Sarzynski SH, Warner S, Sun J, Matsouaka R, Dekker JP, Babiker A, Li W, Lai YL, Danner RL, Fowler VG Jr, Kadri SS. Sarzynski SH, et al. Open Forum Infect Dis. 2022 Jan 17;9(2):ofab644. doi: 10.1093/ofid/ofab644. eCollection 2022 Feb. Open Forum Infect Dis. 2022. PMID: 35097154 Free PMC article.

10

In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth.

Lasko MJ, Gethers ML, Tabor-Rennie JL, Nicolau DP, Kuti JL. Lasko MJ, et al. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0216721. doi: 10.1128/aac.02167-21. Epub 2022 Jan 10. Antimicrob Agents Chemother. 2022. PMID: 35007135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results